Kairos Pharma, Ltd. (KAPA)
KAPA
Loading signal…
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 1.45
- P/E (TTM)
- -0.43
- Short % float
- 1.26%
- Days to cover
- 1.0
- SI change
- -1.1%
- 1W
- -27.83%
- 1M
- -54.89%
- vs SPY 1W
- -27.69%
- vs SPY 1M
- -57.40%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FAQ
- What is LOPJLB’s current signal on KAPA?
- LOPJLB publishes daily direction and regime signals for KAPA on this page.
- What market regime is KAPA in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Kairos Pharma, Ltd. (KAPA) do?
- Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, I…